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Fig.1. the detector response for 10 cm paraffin moderator in front of the source (left) and for 15 cm 
paraffin moderator in front of the source (right). 
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Head and neck cancer belong to the most prevalent cancers, and are the sixth leading cause of cancer 
worldwide. Radiotherapy is an important treatment modality in head and neck cancer. In recent years new radiotherapy 
techniques have been developed. The IMRT technique is characterized by a highly conformal dose distribution to 
targets, whereas a constraint dose to organs at risk (OARs) [1]. Sequential boost (SEQ) intensity-modulated radiation 
therapy regimens for HNC are composed of elective irradiation followed by a series of reduced boost fields aiming at 
the different overall doses needed for tumor control or OARs tolerance. Simultaneous integrated boost (SIB) technique 
gained popularity as it improved planning efficiency and escalated the dose per fraction delivered to the gross target 
volume (GTV) to potentially enhance tumor control [2]. SIB-IMRT is a safe and effective treatment for HNC, whereas 
it offers the following advantages: shortening of the treatment time and increased biologically equivalent dose (BED) 
to the tumor with dose per fraction slightly >2 Gy [3].  
Aim: The purpose of this work was to Compare prescription dose coverage of planning target volume (PTV) 
and complication of organs at risk (OAR) based on dose volume histogram (DVH) from sequential (SEQ) and 
simultaneous integrated boost (SIB) plans delivered with volumetric modulated arc therapy (VMAT) for patients with 
squamous cell cancer of the head and neck (HNSCC). 
Patients and methods: SEQ and SIB plans using VMAT for 10 HNSCC patients were generated and analyzed 
for differences in dose distribution, coverage to the planning target volumes (PTV) 70–50 and sparing of organs at 
risk (OAR). Also, biological effective doses were calculated for PTV70-50, brain stem and spinal cord. 
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Results: Both strategies achieved excellent PTV coverage and satisfactory OAR sparing. Measured Dmean 
were 71.9±0.7 and 61.11±2.95 for PTV70 and PTV50 respectively for SIB, and 72.6±0.3 and 62.9±3.2 for PTV70 
and PTV50 respectively for SEQ (p = 0.002 for PTV70 and p = 0.006 for PTV50). The BED to PTV70 was higher in 
SIB- VMAT than SEQ-VMAT, 92.52±1 Gy10 and 87.58± 0.4 Gy10, respectively (p = 0.002 for PTV70). The mean 
dose of Dmax to the spinal cord and brain stem in SIB VMAT were (39.6. ± 3.7 Gy and 31.3 ± 17.3 Gy) and in SEQ-
VMAT (40.8± 5.6 Gy and 30.5 ± 17.6 Gy) respectively (p= 0.14 for spinal cord and p = 0.25 for brain stem). 
The BED for spinal cord and brain stem were higher in SIB- VMAT than SEQ-VMAT, (70.33 ± 9.3 Gy and 
55.7± 36.1 Gy) and (64.97± 11.5 Gy and 47.8 ± 32.2 Gy) respectively (p = 0.1 for spinal cord and p = 0.12 for brain 
stem). 
Conclusion: The SIB technique is a more effective way of planning and delivering VMAT because it involves 
the use of the same plan for the entire course of treatment. it may have biologic advantages: the ability for dose/fraction 
escalation to a tumor and conformal avoidance of normal tissues. However, tissues embedded in the target volume 
may be at higher risk, and caution must be observed when applying higher than conventional fraction sizes. 
Furthermore, there may be an advantage in terms of higher biologically effective tumor dose and/or lower biologically 
effective dose normal tissues outside the tumor volume. SIB-VMAT may be superior to SEQ-VMAT in its 
convenience and short-course of treatment. However, there is an increased risk of complication due to the high dose 
per fraction and reduction in overall treatment time which leads to increase BED for SC and BS so the risk of 
complications are increased such as myelopathy. In contrast, sequential boost VMAT is more time consuming and 
requires the summation of 2 or more treatment plans, but less risk of complications in comparison to SIB such as 
myelopathy. 
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Нейтрон-захватная терапия – один из методов радиационной терапии для селективного лечения 
злокачественных новообразований головного мозга, шеи, легких и т.д. В основе метода лежит ядерная 
реакция радиационного захвата нейтрона сильнопоглощающими изотопами (B10, Gd157) [1,2]. Традиционно, в 
качестве сильнопоглощающего элемента применяется B10 (бор нейтрон-захватная терапия) с сечением 
поглощения в тепловой области порядка 3800-4000 барн. Основной терапевтический эффект в данном случае 
